rs4980

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000789.4(ACE):​c.3836G>A​(p.Arg1279Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00527 in 1,557,882 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1279P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 26 hom. )

Consequence

ACE
NM_000789.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.24

Publications

26 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0066785812).
BP6
Variant 17-63497281-G-A is Benign according to our data. Variant chr17-63497281-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00528 (804/152260) while in subpopulation NFE AF = 0.007 (476/68004). AF 95% confidence interval is 0.00648. There are 0 homozygotes in GnomAd4. There are 393 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 26 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.3836G>A p.Arg1279Gln missense_variant Exon 25 of 25 ENST00000290866.10 NP_000780.1 P12821-1B4DKH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.3836G>A p.Arg1279Gln missense_variant Exon 25 of 25 1 NM_000789.4 ENSP00000290866.4 P12821-1
ENSG00000264813ENST00000577647.2 linkn.1969+296G>A intron_variant Intron 13 of 30 2 ENSP00000464149.1 F6X3S4

Frequencies

GnomAD3 genomes
AF:
0.00528
AC:
803
AN:
152142
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00333
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00491
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00725
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00700
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00410
AC:
635
AN:
154786
AF XY:
0.00404
show subpopulations
Gnomad AFR exome
AF:
0.00330
Gnomad AMR exome
AF:
0.00238
Gnomad ASJ exome
AF:
0.000603
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00559
Gnomad NFE exome
AF:
0.00658
Gnomad OTH exome
AF:
0.00691
GnomAD4 exome
AF:
0.00527
AC:
7406
AN:
1405622
Hom.:
26
Cov.:
34
AF XY:
0.00524
AC XY:
3639
AN XY:
694598
show subpopulations
African (AFR)
AF:
0.00267
AC:
86
AN:
32230
American (AMR)
AF:
0.00272
AC:
100
AN:
36718
Ashkenazi Jewish (ASJ)
AF:
0.000753
AC:
19
AN:
25216
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36860
South Asian (SAS)
AF:
0.00216
AC:
173
AN:
80138
European-Finnish (FIN)
AF:
0.00751
AC:
348
AN:
46322
Middle Eastern (MID)
AF:
0.00981
AC:
46
AN:
4690
European-Non Finnish (NFE)
AF:
0.00586
AC:
6354
AN:
1085198
Other (OTH)
AF:
0.00481
AC:
280
AN:
58250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
479
958
1438
1917
2396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00528
AC:
804
AN:
152260
Hom.:
0
Cov.:
33
AF XY:
0.00528
AC XY:
393
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00339
AC:
141
AN:
41552
American (AMR)
AF:
0.00484
AC:
74
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4828
European-Finnish (FIN)
AF:
0.00725
AC:
77
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00700
AC:
476
AN:
68004
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00530
Hom.:
0
Bravo
AF:
0.00493
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00284
AC:
12
ESP6500EA
AF:
0.00541
AC:
45
ExAC
AF:
0.00312
AC:
352
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACE: BP4, BS2 -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular dysgenesis Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;.;.
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.83
T;T;T
MetaRNN
Benign
0.0067
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
M;.;.
PhyloP100
2.2
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.051
Sift
Benign
0.083
T;T;T
Sift4G
Uncertain
0.019
D;D;D
Polyphen
0.016
B;B;.
Vest4
0.098
MVP
0.74
MPC
0.11
ClinPred
0.010
T
GERP RS
1.4
Varity_R
0.069
gMVP
0.45
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4980; hg19: chr17-61574642; API